Choosing A Development-Stage eCOA/ePRO Provider
Source: Life Science Leader
By ISR
ISR asked study sponsors, CROs, and clinical research sites what’s the most important attribute they would use to select an eCOA (electronic clinical outcomes assessment)/ ePRO (electronic patient reported outcomes) provider for development-stage products. Since patients are often the ones navigating these applications, it is not surprising to see intuitiveness at the top of the list.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more